Page last updated: 2024-11-05

troglitazone and Brain Inflammation

troglitazone has been researched along with Brain Inflammation in 1 studies

Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sundararajan, S1
Gamboa, JL1
Victor, NA1
Wanderi, EW1
Lust, WD1
Landreth, GE1

Other Studies

1 other study available for troglitazone and Brain Inflammation

ArticleYear
Peroxisome proliferator-activated receptor-gamma ligands reduce inflammation and infarction size in transient focal ischemia.
    Neuroscience, 2005, Volume: 130, Issue:3

    Topics: Animals; Blood Glucose; Brain Chemistry; Cell Count; Cerebrovascular Circulation; Chromans; Dose-Res

2005
chemdatabank.com